During the past decade, Brigham and Women's Hospital- 221 Longwood Avenue conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Brigham and Women's Hospital- 221 Longwood Avenue" are "Diabetes Mellitus" (1 trials) and "Healthy Subjects" (1 trials). Many other conditions were trialed in "Brigham and Women's Hospital- 221 Longwood Avenue" in a lesser frequency.

Most popular intervention types in "Brigham and Women's Hospital- 221 Longwood Avenue" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Angiotensin II" (1 trials), "Norepinephrine" (1 trials), "Para-aminohippuric Acid" (1 trials), "Placebo" (1 trials) and "Pravastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brigham and Women's Hospital- 221 Longwood Avenue" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Brigham and Women's Hospital- 221 Longwood Avenue". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Brigham and Women's Hospital- 221 Longwood Avenue, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brigham and Women's Hospital- 221 Longwood Avenue, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".